Skin Imaging to Inform Laser Treatments
Sponsor: University of California, Irvine
Terminated
All 55 subjects enrolled in the study completed the initial study procedures, but due to the pandemic and the prolonged period where we were unable to follow up patients, we were not able to complete the aims for this protocol.
Other terminated trials from University of California, Irvine
Listed as NCT04336163, this NA trial focuses on Angioma and Port-Wine Stain and remains terminated or withdrawn. Sponsored by University of California, Irvine, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Feb 2024 — Jul 2024 [monthly]
Terminated NA
-
Sep 2022 — Feb 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
May 2022 — Sep 2022 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Oct 2021 — May 2022 [monthly]
Recruiting NA
-
Apr 2021 — Oct 2021 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Sep 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, Irvine
For direct contact, visit the study record on ClinicalTrials.gov .